Sunday, March 16, 2025 | 03:02 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Torrent Pharma slips on acquisition of Elder's formulation biz

The stock was down 7% to Rs 465 on the Bombay Stock Exchange.

SI Reporter Mumbai
Torrent Pharmaceuticals has dipped 7% to Rs 465, after the company said it entered into a definitive agreement to acquire the branded domestic formulation business of Elder Pharmaceuticals for a consideration of Rs 2,004 crore on slump sale basis.

The company would fund the acquisition value through a mix of internal accruals and bank debt, Torrent Pharmaceuticals said in a regulatory filing. The stock opened at Rs 501 and touched a low of Rs 458 on the BSE. A combined 1.24 million shares have changed hands on the counter so far on the BSE and NSE.

Elder Pharmaceuticals too slipped 12% to Rs 288, falling nearly 17% from a intra-day high. The stock opened at Rs 326 and touched high of Rs 349 after the announcements.
 
 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 13 2013 | 2:37 PM IST

Explore News